THE TRUTH ABOUT: National cancer institute | History Defined

Natera's Multi-Cancer Blood Test Gets FDA Breakthrough Status, a Faster Review Path That Is Not an Approval

Natera's multi-cancer blood test won FDA breakthrough status, which is not an approval. What it means, what data are missing, and what to ask.

Medical Daily · 1h ago

Automated Breast Ultrasound Had Fewer False Alarms Than Handheld Scans in Dense Breasts, with No Apparent Detection Drop

A study of 21,446 women with dense breasts found that automated ultrasound had fewer abnormal results than handheld scans. What it means for screening.

Medical Daily · Oct 11

Under-50 Cutoff for Inherited Cancer Testing Would Have Missed 72% of Carriers in Memorial Sloan Kettering Study

An MSK study of 39,184 cancer patients found that an under-50 testing cutoff would miss 72% of inherited variant carriers. What patients should ask.

Medical Daily · Oct 8

Proton Therapy Did Not Help Advanced Liver Cancer Patients Live Longer Than Standard Radiation in Phase 3 Trial

In the Phase 3 NRG-GI003 trial, proton therapy did not extend survival over standard radiation in advanced liver cancer. Here is what patients should ask.

Medical Daily · Oct 1

In Iowa, soaring cancer rates emerge as a key midterms issue

Cancer has emerged as an unusual bipartisan campaign issue in Iowa’s midterm races as the state confronts the second-highest cancer rate in the US. Candidates are linking the debate to healthcare access, cancer screening and worsening water quality, although scientists have not reached a consensus on whether nitrate contamination is…

The Economic Times · Sep 29

HHS and EPA Join Forces on Glyphosate Health Research as EPA Readies Its Cancer Review for Early 2027

HHS and EPA formed a working group to study glyphosate's health effects ahead of EPA's early 2027 review. The agencies say the pact does not decide the outcome.

Medical Daily · Sep 24

California Imaging Center Failed a Federal Image Review and Never Warned the Patients Regulators Ordered It to Contact

FDA is alerting women who had mammograms at a Monterey center since December 2023 after the facility failed a federal image quality review.

Medical Daily · Sep 1

New Cancer Med Is Giving Patients Hope, But One Former Senator Says It Comes With A “Nasty” Catch

The FDA has approved a new cancer treatment. It's a tablet meant to help patients with pancreatic cancer. But the side-effects can be brutal, and visually shocking, despite its success rate. The full story is in the article.

Bored Panda · Aug 28

Large Trial Finds High-Dose Vitamin D Did Not Slow Metastatic Colorectal Cancer

A phase 3 trial in 455 patients found high-dose vitamin D3 did not improve survival in metastatic colorectal cancer, reversing an earlier signal.

Medical Daily · Aug 7

NIH Moves to Cancel More Health Disparities Grants, Halting Studies on Why Some Patients Fare Worse

NIH has resumed terminating health disparities research grants, affecting studies on rural access, maternal mortality and cancer survival gaps.

Medical Daily · Aug 7